Literature DB >> 23645629

Beyond scoring: a modern interpretation of disease progression in chronic liver disease.

Matteo Rosselli1, Jane MacNaughtan, Rajiv Jalan, Massimo Pinzani.   

Abstract

Entities:  

Keywords:  CHRONIC LIVER DISEASE; CIRRHOSIS; FIBROSIS; PORTAL HYPERTENSION

Mesh：

Substances：

Year:  2013        PMID： 23645629     DOI： 10.1136/gutjnl-2012-302826

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  22 in total

1.  Liver and spleen stiffness and their ratio assessed by real-time two dimensional-shear wave elastography in patients with liver fibrosis and cirrhosis due to chronic viral hepatitis.

Authors:  Ivica Grgurevic; Zeljko Puljiz; Darko Brnic; Tomislav Bokun; Renata Heinzl; Anita Lukic; Boris Luksic; Milan Kujundzic; Boris Brkljacic
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

Review 2.  Acute-on-Chronic Liver Failure.

Authors:  Sumeet K Asrani; Douglas A Simonetto; Patrick S Kamath
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-15       Impact factor: 11.382

3.  Increased Bile Acid Signals After Duodenal-Jejunal Bypass Improve Non-alcoholic Steatohepatitis (NASH) in a Rodent Model of Diet-Induced NASH.

Authors:  Takahiro Tsuchiya; Takeshi Naitoh; Munenori Nagao; Naoki Tanaka; Kazuhiro Watanabe; Hirofumi Imoto; Tomohiro Miyachi; Fuyuhiko Motoi; Michiaki Unno
Journal:  Obes Surg       Date:  2018-06       Impact factor: 4.129

4.  Correlation of serum liver fibrosis markers with severity of liver dysfunction in liver cirrhosis: a retrospective cross-sectional study.

Authors:  Cuihong Zhu; Xingshun Qi; Hongyu Li; Ying Peng; Junna Dai; Jiang Chen; Chunlian Xia; Yue Hou; Wenwen Zhang; Xiaozhong Guo
Journal:  Int J Clin Exp Med       Date:  2015-04-15

5.  PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients.

Authors:  Paola Dongiovanni; Marica Meroni; Guido Baselli; Rosellina M Mancina; Massimiliano Ruscica; Miriam Longo; Raffaela Rametta; Annalisa Cespiati; Serena Pelusi; Nicola Ferri; Valeria Ranzani; Valerio Nobili; Jussi Pihlajamaki; Anna Ludovica Fracanzani; Sara Badiali; Salvatore Petta; Silvia Fargion; Stefano Romeo; Julia Kozlitina; Luca Valenti
Journal:  J Lipid Res       Date:  2019-03-27       Impact factor: 5.922

6.  qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients.

Authors:  Shuoyu Xu; Yan Wang; Dean C S Tai; Shi Wang; Chee Leong Cheng; Qiwen Peng; Jie Yan; Yongpeng Chen; Jian Sun; Xieer Liang; Youfu Zhu; Jagath C Rajapakse; Roy E Welsch; Peter T C So; Aileen Wee; Jinlin Hou; Hanry Yu
Journal:  J Hepatol       Date:  2014-02-26       Impact factor: 25.083

Review 7.  Acute-on-chronic liver failure.

Authors:  Sumeet K Asrani; Jacqueline G O'Leary
Journal:  Clin Liver Dis       Date:  2014-08       Impact factor: 6.126

8.  Hepatocyte-specific ablation of PP2A catalytic subunit α attenuates liver fibrosis progression via TGF-β1/Smad signaling.

Authors:  Na Lu; Yun Liu; An Tang; Lulu Chen; Dengshun Miao; Xiaoqin Yuan
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

9.  Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic fatty liver disease.

Authors:  Edoardo Alessandro Pulixi; Eleonora Tobaldini; Pier Maria Battezzati; Paola D'Ingianna; Vittorio Borroni; Anna Ludovica Fracanzani; Marco Maggioni; Serena Pelusi; Mara Bulgheroni; Massimo Zuin; Silvia Fargion; Nicola Montano; Luca Valenti
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

10.  Angiogenesis-related biomarkers in patients with alcoholic liver disease: their association with liver disease complications and outcome.

Authors:  Beata Kasztelan-Szczerbinska; Agata Surdacka; Maria Slomka; Jacek Rolinski; Krzysztof Celinski; Halina Cichoz-Lach; Agnieszka Madro; Mariusz Szczerbinski
Journal:  Mediators Inflamm       Date:  2014-05-18       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.